Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Loa Loa (eye worm) | MH2 domain-containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Brugia malayi | MH2 domain containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Loa Loa (eye worm) | transcription factor SMAD2 | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0111 | 0.7047 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0074 | 0.3809 | 0.228 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0067 | 0.3238 | 0.4161 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0111 | 0.7047 | 1 |
Schistosoma mansoni | DNA polymerase eta | 0.0053 | 0.1981 | 0.5 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.0053 | 0.1981 | 0.5 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0067 | 0.3238 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0051 | 0.1781 | 0.1927 |
Trypanosoma brucei | unspecified product | 0.0096 | 0.5791 | 0.8073 |
Echinococcus multilocularis | dna polymerase kappa | 0.0111 | 0.7047 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0111 | 0.7047 | 1 |
Leishmania major | DNA polymerase kappa, putative | 0.0067 | 0.3238 | 1 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0111 | 0.7047 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0111 | 0.7047 | 1 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0111 | 0.7047 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0111 | 0.7047 | 1 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0053 | 0.1981 | 0.2234 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0074 | 0.3809 | 0.5036 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0111 | 0.7047 | 1 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0111 | 0.7047 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0111 | 0.7047 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0111 | 0.7047 | 1 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0053 | 0.1981 | 0.5 |
Echinococcus granulosus | dna polymerase kappa | 0.0111 | 0.7047 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0051 | 0.1781 | 0.1927 |
Brugia malayi | polk-prov protein | 0.0074 | 0.3809 | 0.228 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0111 | 0.7047 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0051 | 0.1781 | 0.1927 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0067 | 0.3238 | 1 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0096 | 0.5791 | 0.8073 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0111 | 0.7047 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0074 | 0.3809 | 0.5036 |
Giardia lamblia | DINP protein human, muc B family | 0.0067 | 0.3238 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0111 | 0.7047 | 1 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0111 | 0.7047 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0111 | 0.7047 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0111 | 0.7047 | 1 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0053 | 0.1981 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0111 | 0.7047 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0111 | 0.7047 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 12.5893 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53 Null Cells at the Permissive Temperature. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 37.933 uM | PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 112.2018 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.